Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Onken, Lori Worley, D. Char, J. Augsburger, Z. Corrêa, E. Nudleman, T. Aaberg, M. Altaweel, D. Bardenstein, P. Finger, B. Gallie, G. Harocopos, P. Hovland, H. McGowan, T. Milman, P. Mruthyunjaya, E. Simpson, Morton Smith, David Wilson, W. Wirostko, J. Harbour (2012)
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.Ophthalmology, 119 8
M. Thurin, F. Marincola (2014)
Molecular Diagnostics for Melanoma
Xue Wu, Yiqun Yuan, R. Ma, Binbin Xu, Rui Zhang (2019)
lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell linesOncology Letters, 19
Harbour (2014)
A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.Methods Mol Biol, 1102
F. Nathan, D. Berd, T. Sato, J. Shield, C. Shields, P. Potter, M. Mastrangelo (1997)
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.Journal of experimental & clinical cancer research : CR, 16 2
Songtian Che, L. Bie, Xu Li, Hui Qi, P. Yu, Ling Zuo (2019)
Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells.International journal of ophthalmology, 12 10
S. Walter, Dan Chao, W. Feuer, J. Schiffman, D. Char, J. Harbour (2016)
Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.JAMA ophthalmology, 134 7
J. Luke, M. Callahan, M. Postow, E. Romano, N. Ramaiya, M. Bluth, A. Giobbie-Hurder, D. Lawrence, N. Ibrahim, P. Ott, K. Flaherty, R. Sullivan, J. Harding, S. D’Angelo, M. Dickson, G. Schwartz, P. Chapman, J. Wolchok, F. Hodi, R. Carvajal (2013)
Clinical activity of ipilimumab for metastatic uveal melanomaCancer, 119
E. Kujala, T. Mäkitie, T. Kivelä (2003)
Very long-term prognosis of patients with malignant uveal melanoma.Investigative ophthalmology & visual science, 44 11
S. Agarwala, R. Panikkar, J. Kirkwood (2004)
Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liverMelanoma Research, 14
T. Kivelä, S. Suciu, J. Hansson, W. Kruit, M. Vuoristo, O. Kloke, M. Gore, M. Hahka‐Kemppinen, L. Parvinen, E. Kumpulainen, Y. Humblet, S. Pyrhönen (2003)
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.European journal of cancer, 39 8
L. Bergman, S. Seregard, B. Nilsson, G. Lundell, U. Ringborg, B. Ragnarsson-Olding (2003)
Uveal melanoma survival in Sweden from 1960 to 1998.Investigative ophthalmology & visual science, 44 8
J. Augsburger, Z. Corrêa, Adeel Shaikh (2009)
Effectiveness of treatments for metastatic uveal melanoma.American journal of ophthalmology, 148 1
A. Algazi, K. Tsai, A. Shoushtari, R. Munhoz, Z. Eroglu, J. Piulats, P. Ott, Douglas Johnson, Jimmy Hwang, A. Daud, J. Sosman, R. Carvajal, B. Chmielowski, M. Postow, J. Weber, R. Sullivan (2016)
Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodiesCancer, 122
Luke (2013)
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.Cancer, 119
K. Komatsubara, D. Manson, R. Carvajal (2016)
Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.Future oncology, 12 11
S. Leyvraz, S. Piperno-Neumann, S. Suciu, J. Baurain, M. Zdzienicki, A. Testori, E. Marshall, M. Scheulen, T. Jouary, S. Négrier, J. Vermorken, E. Kaempgen, X. Durando, D. Schadendorf, R. Gurunath, U. Keilholz (2014)
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.Annals of oncology : official journal of the European Society for Medical Oncology, 25 3
M. Diener-West, S. Reynolds, Donna Agugliaro, R. Caldwell, K. Cumming, J. Earle, Donna Green, B. Hawkins, J. Hayman, I. Jaiyesimi, J. Kirkwood, W. Koh, D. Robertson, J. Shaw, J. Thoma (2004)
Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 12
E. Gragoudas, Wenjun Li, M. Goitein, A. Lane, J. Munzenrider, K. Egan (2002)
Evidence-based estimates of outcome in patients irradiated for intraocular melanoma.Archives of ophthalmology, 120 12
L. Kottschade, R. McWilliams, S. Markovic, M. Block, Jose Bisneto, A. Pham, B. Esplin, R. Dronca (2016)
The use of pembrolizumab for the treatment of metastatic uveal melanomaMelanoma Research, 26
Gustav Stålhammar, T. See, Stephen Phillips, H. Grossniklaus (2019)
Density of PAS positive patterns in uveal melanoma: Correlation with vasculogenic mimicry, gene expression class, BAP-1 expression, macrophage infiltration, and risk for metastasisMolecular Vision, 25
K. Guenterberg, V. Grignol, Kiran Relekar, K. Varker, Helen Chen, K. Kendra, T. Olencki, W. Carson (2011)
A Pilot Study of Bevacizumab and Interferon-&agr;2b in Ocular MelanomaAmerican Journal of Clinical Oncology, 34
Glenda Delgado-Ramos, Fridtjof Thomas, A. Vanderwalde, Benjamin King, M. Wilson, A. Pallera (2019)
Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysisMedical Oncology, 36
J. Augsburger, Z. Corrêa, N. Trichopoulos (2011)
Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.American journal of ophthalmology, 152 1
R. Carvajal, J. Sosman, J. Quevedo, M. Milhem, A. Joshua, R. Kudchadkar, G. Linette, T. Gajewski, J. Lutzky, D. Lawson, C. Lao, P. Flynn, M. Albertini, Takami Sato, K. Lewis, A. Doyle, K. Ancell, K. Panageas, M. Bluth, C. Hedvat, J. Erinjeri, G. Ambrosini, B. Marr, D. Abramson, M. Dickson, J. Wolchok, P. Chapman, G. Schwartz (2014)
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.JAMA, 311 23
E. Gragoudas, Kathleen Egan, J. Seddon, Robert Glynn, S. Walsh, Susan Finn, J. Munzenrider, M. Spar (1991)
Survival of patients with metastases from uveal melanoma.Ophthalmology, 98 3
Lawrence Flaherty, Joseph Unger, Poching Liu, Wilson Mertens, V. Sondak (1998)
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials.American journal of clinical oncology, 21 6
R. Carvajal, G. Schwartz, T. Tezel, B. Marr, J. Francis, P. Nathan (2016)
Metastatic disease from uveal melanoma: treatment options and future prospectsThe British Journal of Ophthalmology, 101
Key PointsQuestionHave there been meaningful improvements in survival rates among patients who were treated for metastatic uveal melanoma? FindingIn this cohort study of patients who were treated between 1982 and 2009 and received a diagnosis of metastasis through 2011, there were similar differences in survival rates between patients who received treatment for metastasis and those who did not compared with patients who were treated for uveal melanoma between 1975 and 1987 who developed metastasis through 1988. MeaningDespite the development of new therapeutics, these findings suggest that significant treatment advances for metastatic uveal melanoma have not been made; further research to identify effective treatments is necessary.
JAMA Ophthalmology – American Medical Association
Published: Sep 28, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.